Its a collaborative trial Mangoman. I am sure J&J wrote some conditions of exclustivity into the contract, but exactly what we will never know. But its a collaboration so J&J must have some exclusitivity. I think its been forgotten over the years (these trials do take years at the best of time, then throw in COVID) that this is a collaborative trial with J&J as involved as OCC - just with domestic surgeons running the practicalities.
"Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, for its Ortho-ATI® stem cell approach for the regeneration of degenerate tendons and ligaments. The collaboration was facilitated by Johnson & Johnson Innovation." (2017)
We should get the final data next week. I wouldn't expect a partnership to be announced with it, but that will hopefully follow. We know the stock consistently spikes on trial announcements of course.
- Forums
- ASX - By Stock
- OCC
- OCC Trading
OCC Trading, page-1019
-
- There are more pages in this discussion • 763 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $96.40M |
Open | High | Low | Value | Volume |
46.8¢ | 47.0¢ | 46.0¢ | $37.16K | 79.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 4123 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 0.450 |
2 | 27010 | 0.445 |
3 | 82109 | 0.440 |
2 | 19005 | 0.430 |
1 | 40000 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 4123 | 2 |
0.470 | 38987 | 5 |
0.475 | 5000 | 1 |
0.480 | 247655 | 11 |
0.490 | 105080 | 2 |
Last trade - 15.28pm 17/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |